154 related articles for article (PubMed ID: 10897169)
1. Re: Mazarati et al. "...clinically available [antiepileptic drug] with a moderate affinity for the glycine site of the N-methyl-D-aspartate (NMDA) receptor".
Rogawski MA; Wasterlain CG; Mazarati AM
Epilepsia; 2000 Jul; 41(7):918-9. PubMed ID: 10897169
[No Abstract] [Full Text] [Related]
2. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
[TBL] [Abstract][Full Text] [Related]
3. Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration.
Taylor LA; McQuade RD; Tice MA
Eur J Pharmacol; 1995 Apr; 289(2):229-33. PubMed ID: 7621896
[TBL] [Abstract][Full Text] [Related]
4. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
[TBL] [Abstract][Full Text] [Related]
5. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit.
Harty TP; Rogawski MA
Epilepsy Res; 2000 Mar; 39(1):47-55. PubMed ID: 10690753
[TBL] [Abstract][Full Text] [Related]
6. Felbamate pharmacology and use in epilepsy.
Burdette DE; Sackellares JC
Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688
[TBL] [Abstract][Full Text] [Related]
7. Felbamate block of the N-methyl-D-aspartate receptor.
Subramaniam S; Rho JM; Penix L; Donevan SD; Fielding RP; Rogawski MA
J Pharmacol Exp Ther; 1995 May; 273(2):878-86. PubMed ID: 7752093
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of felbamate and other compounds on N-methyl-D-aspartic acid-induced convulsions and lethality in mice.
Sofia RD; Gordon R; Gels M; Diamantis W
Pharmacol Res; 1994; 29(2):139-44. PubMed ID: 8058587
[TBL] [Abstract][Full Text] [Related]
9. Felbamate modulates the strychnine-insensitive glycine receptor.
White HS; Harmsworth WL; Sofia RD; Wolf HH
Epilepsy Res; 1995 Jan; 20(1):41-8. PubMed ID: 7713059
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the gating conformational changes in the felbamate binding site in NMDA channels.
Chang HR; Kuo CC
Biophys J; 2007 Jul; 93(2):456-66. PubMed ID: 17468173
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs.
Macdonald RL; Kelly KM
Epilepsia; 1994; 35 Suppl 4():S41-50. PubMed ID: 7513639
[TBL] [Abstract][Full Text] [Related]
12. Felbamate increases [3H]glycine binding in rat brain and sections of human postmortem brain.
McCabe RT; Sofia RD; Layer RT; Leiner KA; Faull RL; Narang N; Wamsley JK
J Pharmacol Exp Ther; 1998 Aug; 286(2):991-9. PubMed ID: 9694960
[TBL] [Abstract][Full Text] [Related]
13. Excitoprotective effect of felbamate in cultured cortical neurons.
Kanthasamy AG; Matsumoto RR; Gunasekar PG; Trunong DD
Brain Res; 1995 Dec; 705(1-2):97-104. PubMed ID: 8821739
[TBL] [Abstract][Full Text] [Related]
14. Selective antagonism of the anticonvulsant effects of felbamate by glycine.
Coffin V; Cohen-Williams M; Barnett A
Eur J Pharmacol; 1994 Apr; 256(2):R9-10. PubMed ID: 8050461
[TBL] [Abstract][Full Text] [Related]
15. Update on the mechanism of action of antiepileptic drugs.
Meldrum BS
Epilepsia; 1996; 37 Suppl 6():S4-11. PubMed ID: 8941036
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors.
Rho JM; Donevan SD; Rogawski MA
Ann Neurol; 1994 Feb; 35(2):229-34. PubMed ID: 8109904
[TBL] [Abstract][Full Text] [Related]
17. Felbamate: interaction with glycine receptors in human cerebral cortex.
Wamsley JK; Sofia RD; Faull RL; Narang N; Ary T; Gan XD; McCabe RT
Proc West Pharmacol Soc; 1994; 37():81-3. PubMed ID: 7984680
[No Abstract] [Full Text] [Related]
18. Enhanced glutamatergic transmission reduces the anticonvulsant potential of lamotrigine but not of felbamate against tonic-clonic seizures.
Tomczyk T; Haberek G; Zuchora B; Jarosławska-Zych A; Kowalczyk MS; Wielosz M; Urbańska EM
Pharmacol Rep; 2007; 59(4):462-6. PubMed ID: 17901576
[TBL] [Abstract][Full Text] [Related]
19. Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats.
Kretschmer BD
Neurosci Lett; 1994 Sep; 179(1-2):115-8. PubMed ID: 7845605
[TBL] [Abstract][Full Text] [Related]
20. Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors.
McCabe RT; Wasterlain CG; Kucharczyk N; Sofia RD; Vogel JR
J Pharmacol Exp Ther; 1993 Mar; 264(3):1248-52. PubMed ID: 8383742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
